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Bleeding represents the most recognised and feared complications of antithrombotic
drugs including oral anticoagulants. Previous studies showed inconsistent results on
the safety profile. Among explanations, bleeding definition could vary and
classification bias exist related to the lack of medical evaluation. To quantify the risk
of major haemorrhagic event and event-free survival associated with antithrombotic
drugs (Vitamin K Antagonist [VKA], non-VKA anticoagulant [NOAC], antiplatelet
agent, parenteral anticoagulant) in 2012-2015, we linked the French nationwide
Health Insurance database (SNIIRAM) with a local "emergency database" (clinical
and biological data collected in clinical records). In the VKA-NOAC comparison, a Cox
regression analysis will be used to estimate the hazard ratio of major haemorrhagic
event adjusted on gender, modified HAS-BLED score and comorbidities. A distinction
on the type of major haemorrhagic event (intracranial, gastrointestinal and other
haemorrhagic events) was made. We present here the study protocol and the
databases linkage results. Using six linkage keys, among 3,837,557 hospital visits
identified in SNIIRAM, 5264 have been matched with a major haemorrhagic event
identified in the "emergency database", thus clinically confirmed. The 1090
unmatched haemorrhagic events could be explained by the fact that patients were not
extracted in the SNIIRAM database (patients living in accommodation establishment
with internal use pharmacy, military people with specific insurance…). We showed
the value of SNIIRAM enrichment with a clinical database, a necessary step to
categorise haemorrhagic events by a clinically relevant definition and medical
validation; it will allow to estimate more accuracy each type of haemorrhagic event.
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